Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Spironolactone is effective and safe for treating hair loss, excessive hair growth, and acne.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Cal/BD aerosol foam effectively treats scalp psoriasis, improving symptoms and patient satisfaction.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

AC5 improves hair loss and hair quality with high satisfaction rates.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Baricitinib significantly regrows hair in teens with severe alopecia areata.